HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"count": 1608389,
"next": "http://info.mzalendo.com/api/v0.1/hansard/entries/?format=api&page=140276",
"previous": "http://info.mzalendo.com/api/v0.1/hansard/entries/?format=api&page=140274",
"results": [
{
"id": 1419161,
"url": "http://info.mzalendo.com/api/v0.1/hansard/entries/1419161/?format=api",
"text_counter": 213,
"type": "speech",
"speaker_name": "Sen. Mandago",
"speaker_title": "",
"speaker": {
"id": 13577,
"legal_name": "Kiplagat Jackson Mandago",
"slug": "kiplagat-jackson-mandago"
},
"content": "The attention of the Standing Committee on Health has been drawn to a press release by the Kenya Renal Association, dated 3rd May 2024, regarding unethical transplant activities at Mediheal Hospital in Eldoret. The statement from the Kenya Renal Association has raised serious concerns about the reported commercialization of transplants and transplant tourism at Mediheal Hospital in Eldoret. The allegations involved the sale of kidneys from vulnerable donors and the importation of patients for transplants; actions that directly violate the Health Act of 2017, which strictly prohibits organ trafficking. Such unethical practices not only undermine the integrity of the medical profession, but also tarnish the reputation of the Kenyan medical community on an international scale. The unethical trade in organs has led to a decline in voluntary donations and has forced a dangerous black market for organs, posing unprecedented risks to human life. This environment not only encourages trafficking, but also increases the likelihood of violence and exploitation. In addition to the immediate risk to human life posed by the organ trafficking black market, it is crucial to recognize the broader societal implications of such an ethical practice. It erodes trust in the healthcare system, undermining the principle of medical ethics and perpetuating injustices against vulnerable individuals who are coerced or exploited into donating organs. While Mediheal Hospital has been singled out by the Kenya Renal Association, it is essential to understand that the illegal trafficking of human organs is not isolated to just one institution. Rather, it is indicative of a complex and growing global problem that involves various individual networks and facilities across the nation, region and abroad and thus necessitates a thorough investigation. This is to inform this House that my committee is well seized of this matter and will be engaging the Cabinet Secretary for Health, the Kenyan Medical Practitioners and Dentists Council, the Kenyan Tissue and Transplant Authority and affected communities with a view of ensuring that robust and immediate action is taken and comprehensive efforts are initiated for purposes of strengthening regulation, promotion of ethical practice and building public awareness. Mr. Temporary Speaker, Sir, I want to further appeal to the Chairperson of the Standing Committee of the National Security, Defense, and Foreign Relations to engage all necessary government agencies and departments to ensure that these criminal activities are brought to an immediate halt. I thank you. Mr. Temporary Speaker, Sir, allow me to also make another statement."
},
{
"id": 1419162,
"url": "http://info.mzalendo.com/api/v0.1/hansard/entries/1419162/?format=api",
"text_counter": 214,
"type": "heading",
"speaker_name": "",
"speaker_title": "",
"speaker": null,
"content": "REPORTS OF TOXIC BENYLIN PAEDIATRIC COUGH SYRUP IN THE MARKET"
},
{
"id": 1419163,
"url": "http://info.mzalendo.com/api/v0.1/hansard/entries/1419163/?format=api",
"text_counter": 215,
"type": "other",
"speaker_name": "",
"speaker_title": "",
"speaker": null,
"content": "Mr. Temporary Speaker, Sir, pursuant to Standing Order No.56(1)(a), I beg to make a statement relating to a matter for which the Standing Committee on Health is responsible, namely the presence of toxic Benylin paediatric cough syrup in the Kenya market."
},
{
"id": 1419164,
"url": "http://info.mzalendo.com/api/v0.1/hansard/entries/1419164/?format=api",
"text_counter": 216,
"type": "other",
"speaker_name": "",
"speaker_title": "",
"speaker": null,
"content": "The electronic version of the Senate Hansard Report is for information purposesonly. A certified version of this Report can be obtained from the Director, Hansard and AudioServices, Senate."
},
{
"id": 1419165,
"url": "http://info.mzalendo.com/api/v0.1/hansard/entries/1419165/?format=api",
"text_counter": 217,
"type": "other",
"speaker_name": "",
"speaker_title": "",
"speaker": null,
"content": "The attention of the Standing Committee on Health has been drawn to an alarming press report on the presence of toxic Benylin paediatric cough syrup in the Kenya market. Benylin cough syrup is widely used to alleviate cough, chest congestion, hay fever and allergic reactions in children between the ages of 2 and 12 years old. On 11th April, 2024, the Pharmacy and Poisons Board issued a public alert and announced the recall of Benylin Paediatric 100 ml Cough Syrup, Batch No.329304. The syrup was manufactured by Johnson & Johnson in South Africa. The recall was prompted by an announcement from Nigeria's National Agency for Food, Drug Administration and Control, which revealed unacceptable high levels of diethylene-glycol and ethylene- glycol in the product upon analysis. Both substances are associated with acute toxicity and have been linked to the deaths of numerous children in Gambia, Uzbekistan and Cameroon since 2022. Aside from deaths, ingestion of high levels of this substance can lead to severe side effects, including abdominal pain, vomiting, diarrhoea, altered mental states and acute kidney injury. It is indeed concerning that the Pharmacy and Poisons Board did not detect the issue with the Benylin cough syrup sooner, especially considering its impending expiration in April, 2024. The lack of clarity regarding the syrup's presence in the market, the number of affected children, the extent of the recall and the potential existence of similar harmful products raises significant concerns about public safety and regulatory oversight. Urgent action is needed to ensure a thorough investigation into the extent of the issue, achieve a comprehensive recall of the affected product and prevent the circulation of similar harmful substances in the market. Ensuring the safety and well-being of our children is a fundamental responsibility of any society. I want to assure this House that my committee is fully aware of the gravity of this matter and will be actively engaging with the Ministry of Health and the Pharmacy and Poisons Board to gather comprehensive information and establish the facts surrounding the toxic cough syrup issue. We are further committed to understanding the actions taken by the government to enhance pharmacovigilance and post-marketing surveillance in the country. I thank you."
},
{
"id": 1419166,
"url": "http://info.mzalendo.com/api/v0.1/hansard/entries/1419166/?format=api",
"text_counter": 218,
"type": "speech",
"speaker_name": "Sen. Wakiliu Sigei",
"speaker_title": "The Temporary Speaker",
"speaker": null,
"content": " Hon. Members, we are way beyond the Statement Hour. As a consequence, I will not allow any comment on these three statements that have just been read out; the first one by Sen. Tabitha Keroche under Standing Order No.52, and two by Senator Mandago, under Standing Order No.56. I will, therefore, call the Next Order."
},
{
"id": 1419167,
"url": "http://info.mzalendo.com/api/v0.1/hansard/entries/1419167/?format=api",
"text_counter": 219,
"type": "heading",
"speaker_name": "",
"speaker_title": "",
"speaker": null,
"content": "BILL"
},
{
"id": 1419168,
"url": "http://info.mzalendo.com/api/v0.1/hansard/entries/1419168/?format=api",
"text_counter": 220,
"type": "scene",
"speaker_name": "",
"speaker_title": "",
"speaker": null,
"content": "First Reading"
},
{
"id": 1419169,
"url": "http://info.mzalendo.com/api/v0.1/hansard/entries/1419169/?format=api",
"text_counter": 221,
"type": "heading",
"speaker_name": "",
"speaker_title": "",
"speaker": null,
"content": "THE INTERGOVERNMENTAL RELATIONS (AMENDMENT) BILL (SENATE BILLS NO.12 OF 2024)"
},
{
"id": 1419170,
"url": "http://info.mzalendo.com/api/v0.1/hansard/entries/1419170/?format=api",
"text_counter": 222,
"type": "other",
"speaker_name": "",
"speaker_title": "",
"speaker": null,
"content": "The electronic version of the Senate Hansard Report is for information purposesonly. A certified version of this Report can be obtained from the Director, Hansard and AudioServices, Senate."
}
]
}